News
This was the ADR's second consecutive day of losses.
(Reuters) -AstraZeneca said on Tuesday that U.S. regulators have approved its precision drug Datroway to treat a type of lung ...
6d
News-Medical.Net on MSNBMJ investigation raises new concerns over ticagrelor approval trialsIn a follow up investigation into the multibillion dollar drug ticagrelor, The BMJ has uncovered fresh concerns, this time in ...
Check out our AZN stock chart to see a history of performance, current stock value, and a timeline of financial events & indicators for a full analysis today.
Review the current AstraZeneca PLC ADR (AZN:XNAS) growth, profitability and efficiency, financial health, and cash flow key metrics to decide if AZN is the best investment for you.
DelveInsight's BAFF- and APRIL-targeted Therapies Market Size, Target Population, Competitive Landscape & Market Forecast ...
According to a new comprehensive report from The Insight Partners, the global ovarian cancer drugs market is observing ...
Eli Lilly & Co.’s experimental weight-loss pill helped patients shed pounds without serious side effects in a clinical trial, ...
Rene Anthony Andrada Haas currently works at ARM Ltd. (United Kingdom), as Chief Executive Officer & Director from 2022, ARM, Inc., as Chief Executive Officer, Arm Holdings Plc, as Chief Executive ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results